anti-BCMA/CD70-CAR-T cells
/ Chongqing Precision Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 19, 2025
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: The Children's Hospital of Zhejiang University School of Medicine
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus • CD70
1 to 1
Of
1
Go to page
1